Claris Financial LLC: AXP position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Claris Financial LLC on AXP, newest first. How the timeline and the estimate are built.
Claris Financial LLC held 1,173 AXP shares at 2026-03-31 per its 13F-HR filed 2026-05-18.
the latest 13F is the newest step
- period ended2026-03-3113F 1,173 sharesChange vs previous 13F +2 shares
0.19% of the 13F portfolio, value $354,713.
13F-HR 0001213900-26-058149 filed by Claris Financial LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,171 sharesChange vs previous 13F +135 shares
0.23% of the 13F portfolio, value $433,267.
13F-HR 0001213900-26-018373 filed by Claris Financial LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,036 sharesChange vs previous 13F +68 shares
0.2% of the 13F portfolio, value $343,965.
13F-HR 0001213900-26-040912 filed by Claris Financial LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 968 sharesChange vs previous 13F +4 shares
0.23% of the 13F portfolio, value $308,694.
13F-HR 0001213900-25-080559 filed by Claris Financial LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 964 sharesChange vs previous 13F 0 shares
0.19% of the 13F portfolio, value $286,242.
13F-HR 0001213900-25-055338 filed by Claris Financial LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 964 sharesChange vs previous 13F not available
0.19% of the 13F portfolio, value $286,242.
13F-HR 0001213900-25-054892 filed by Claris Financial LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).